Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 44 | 2024 | 6692 | 3.280 |
Why?
|
Aspirin | 13 | 2024 | 3209 | 1.880 |
Why?
|
Aberrant Crypt Foci | 3 | 2017 | 11 | 1.560 |
Why?
|
Anticarcinogenic Agents | 3 | 2018 | 248 | 1.140 |
Why?
|
Escherichia coli Proteins | 3 | 2024 | 1050 | 1.140 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 7 | 2024 | 2246 | 1.130 |
Why?
|
Fibroblast Growth Factors | 3 | 2020 | 856 | 1.090 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2017 | 593 | 0.890 |
Why?
|
Adenoma | 6 | 2021 | 2122 | 0.880 |
Why?
|
Body Composition | 3 | 2020 | 2335 | 0.840 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2023 | 383 | 0.790 |
Why?
|
Chemoprevention | 3 | 2020 | 319 | 0.790 |
Why?
|
Escherichia coli | 3 | 2024 | 4166 | 0.750 |
Why?
|
Cryoelectron Microscopy | 1 | 2024 | 591 | 0.740 |
Why?
|
Renal Dialysis | 3 | 2024 | 1663 | 0.720 |
Why?
|
Feces | 6 | 2021 | 1386 | 0.720 |
Why?
|
Potassium | 1 | 2024 | 1303 | 0.700 |
Why?
|
Liposomes | 1 | 2023 | 759 | 0.700 |
Why?
|
Prokaryotic Cells | 1 | 2018 | 47 | 0.650 |
Why?
|
Health | 1 | 2020 | 391 | 0.600 |
Why?
|
Dinoprostone | 1 | 2020 | 596 | 0.590 |
Why?
|
Eukaryotic Cells | 1 | 2018 | 192 | 0.590 |
Why?
|
Carcinoma | 3 | 2017 | 2343 | 0.570 |
Why?
|
Dietary Fiber | 4 | 2024 | 751 | 0.560 |
Why?
|
Stomach Neoplasms | 2 | 2022 | 1320 | 0.510 |
Why?
|
Membrane Proteins | 3 | 2018 | 7748 | 0.500 |
Why?
|
Colonic Polyps | 2 | 2019 | 530 | 0.490 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2023 | 2098 | 0.470 |
Why?
|
Smoking | 5 | 2023 | 8876 | 0.470 |
Why?
|
Data Collection | 2 | 2020 | 3270 | 0.470 |
Why?
|
International Cooperation | 1 | 2020 | 1400 | 0.450 |
Why?
|
Aging | 4 | 2020 | 8374 | 0.450 |
Why?
|
Genome-Wide Association Study | 8 | 2024 | 12039 | 0.450 |
Why?
|
Microsatellite Instability | 6 | 2024 | 695 | 0.450 |
Why?
|
Hypertension | 3 | 2023 | 8197 | 0.430 |
Why?
|
Colonoscopy | 3 | 2017 | 1335 | 0.430 |
Why?
|
Coronavirus Infections | 5 | 2020 | 2997 | 0.420 |
Why?
|
Postprandial Period | 4 | 2021 | 298 | 0.420 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3105 | 0.420 |
Why?
|
Colonic Neoplasms | 4 | 2020 | 2488 | 0.410 |
Why?
|
Salicylic Acid | 1 | 2021 | 55 | 0.400 |
Why?
|
Metagenome | 5 | 2023 | 410 | 0.400 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 476 | 0.390 |
Why?
|
Polymorphism, Single Nucleotide | 10 | 2024 | 15221 | 0.390 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 481 | 0.390 |
Why?
|
Risk Factors | 34 | 2024 | 70952 | 0.370 |
Why?
|
Diet | 10 | 2024 | 7832 | 0.360 |
Why?
|
Hyperplasia | 1 | 2013 | 1145 | 0.350 |
Why?
|
Kidney Failure, Chronic | 2 | 2024 | 2424 | 0.350 |
Why?
|
Aged | 46 | 2024 | 161495 | 0.350 |
Why?
|
Humans | 104 | 2024 | 735458 | 0.340 |
Why?
|
Prospective Studies | 31 | 2024 | 52611 | 0.340 |
Why?
|
Immunoassay | 1 | 2013 | 733 | 0.340 |
Why?
|
Genetic Predisposition to Disease | 8 | 2024 | 17201 | 0.330 |
Why?
|
Fruit | 1 | 2024 | 1136 | 0.320 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1738 | 0.320 |
Why?
|
Vegetables | 1 | 2024 | 1175 | 0.320 |
Why?
|
Proto-Oncogene Proteins B-raf | 6 | 2024 | 2025 | 0.310 |
Why?
|
Fusobacterium nucleatum | 2 | 2021 | 163 | 0.310 |
Why?
|
Colon | 3 | 2021 | 1755 | 0.300 |
Why?
|
Cell Membrane | 1 | 2017 | 3685 | 0.300 |
Why?
|
Self Report | 8 | 2022 | 3526 | 0.300 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2019 | 1047 | 0.300 |
Why?
|
Cognition | 6 | 2024 | 6696 | 0.300 |
Why?
|
Irritable Bowel Syndrome | 2 | 2023 | 432 | 0.300 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2023 | 373 | 0.300 |
Why?
|
Male | 59 | 2024 | 346169 | 0.290 |
Why?
|
Proteomics | 3 | 2020 | 3618 | 0.290 |
Why?
|
Middle Aged | 47 | 2024 | 211305 | 0.280 |
Why?
|
Female | 59 | 2024 | 376708 | 0.280 |
Why?
|
Folic Acid | 1 | 2023 | 1281 | 0.280 |
Why?
|
Neuropsychological Tests | 3 | 2024 | 6916 | 0.270 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 2036 | 0.270 |
Why?
|
Vaccination | 4 | 2022 | 3200 | 0.270 |
Why?
|
Incidence | 9 | 2024 | 20493 | 0.270 |
Why?
|
Blood Pressure | 2 | 2023 | 8258 | 0.260 |
Why?
|
CpG Islands | 5 | 2024 | 1180 | 0.250 |
Why?
|
Potassium-Hydrogen Antiporters | 1 | 2024 | 2 | 0.250 |
Why?
|
Kidney Transplantation | 2 | 2024 | 4070 | 0.240 |
Why?
|
Probenecid | 1 | 2024 | 74 | 0.240 |
Why?
|
Mendelian Randomization Analysis | 3 | 2024 | 923 | 0.240 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5612 | 0.230 |
Why?
|
Glucose Transporter Type 3 | 1 | 2023 | 16 | 0.230 |
Why?
|
Blood Glucose | 4 | 2021 | 6097 | 0.230 |
Why?
|
Molecular Dynamics Simulation | 2 | 2024 | 393 | 0.230 |
Why?
|
Antiporters | 2 | 2022 | 274 | 0.230 |
Why?
|
Microdissection | 2 | 2014 | 150 | 0.220 |
Why?
|
Recombinant Fusion Proteins | 1 | 2012 | 3712 | 0.220 |
Why?
|
Feeding Behavior | 4 | 2021 | 3156 | 0.220 |
Why?
|
Glucose Transporter Type 1 | 1 | 2023 | 189 | 0.220 |
Why?
|
Case-Control Studies | 8 | 2024 | 21459 | 0.210 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2023 | 176 | 0.210 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1824 | 0.200 |
Why?
|
Histidine | 1 | 2022 | 307 | 0.200 |
Why?
|
Ions | 1 | 2022 | 260 | 0.200 |
Why?
|
Ageusia | 1 | 2021 | 18 | 0.200 |
Why?
|
Glutathione | 1 | 2024 | 566 | 0.200 |
Why?
|
Pandemics | 8 | 2022 | 8241 | 0.190 |
Why?
|
DNA Glycosylases | 1 | 2022 | 123 | 0.190 |
Why?
|
Proportional Hazards Models | 7 | 2022 | 12113 | 0.190 |
Why?
|
Patient Discharge | 1 | 2024 | 3254 | 0.190 |
Why?
|
Follow-Up Studies | 14 | 2023 | 38356 | 0.190 |
Why?
|
Biological Assay | 1 | 2024 | 632 | 0.190 |
Why?
|
Saccharomyces cerevisiae | 1 | 2012 | 2677 | 0.190 |
Why?
|
Cough | 2 | 2021 | 557 | 0.190 |
Why?
|
Disease Progression | 6 | 2023 | 13117 | 0.190 |
Why?
|
Obesity | 4 | 2023 | 12502 | 0.180 |
Why?
|
Membrane Transport Proteins | 2 | 2024 | 1021 | 0.180 |
Why?
|
Mutation | 9 | 2024 | 29406 | 0.180 |
Why?
|
Kidney Tubules | 1 | 2022 | 465 | 0.180 |
Why?
|
Adult | 36 | 2024 | 212371 | 0.180 |
Why?
|
Progestins | 1 | 2022 | 301 | 0.180 |
Why?
|
Disease Notification | 1 | 2020 | 95 | 0.170 |
Why?
|
DNA Methylation | 6 | 2024 | 4186 | 0.170 |
Why?
|
Protein Stability | 2 | 2018 | 545 | 0.170 |
Why?
|
Precancerous Conditions | 2 | 2019 | 958 | 0.170 |
Why?
|
Risk Assessment | 8 | 2024 | 22901 | 0.170 |
Why?
|
Dyspnea | 3 | 2021 | 1281 | 0.170 |
Why?
|
Appetite | 1 | 2021 | 241 | 0.170 |
Why?
|
Masks | 1 | 2021 | 196 | 0.160 |
Why?
|
Longitudinal Studies | 6 | 2024 | 13817 | 0.160 |
Why?
|
Time Factors | 9 | 2021 | 39212 | 0.160 |
Why?
|
Glucosinolates | 1 | 2018 | 10 | 0.160 |
Why?
|
Mass Spectrometry | 2 | 2017 | 2162 | 0.160 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 787 | 0.160 |
Why?
|
Isothiocyanates | 1 | 2018 | 48 | 0.150 |
Why?
|
Systole | 2 | 2020 | 904 | 0.150 |
Why?
|
Diastole | 2 | 2020 | 750 | 0.150 |
Why?
|
Gene Expression | 3 | 2020 | 7578 | 0.150 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2022 | 2507 | 0.150 |
Why?
|
Young Adult | 15 | 2022 | 56151 | 0.150 |
Why?
|
United States | 15 | 2022 | 69005 | 0.150 |
Why?
|
Cohort Studies | 10 | 2024 | 39931 | 0.150 |
Why?
|
Mammals | 1 | 2023 | 1130 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 241 | 0.150 |
Why?
|
Prognosis | 8 | 2021 | 28548 | 0.150 |
Why?
|
Sodium | 1 | 2022 | 1578 | 0.150 |
Why?
|
Genetic Loci | 3 | 2024 | 2532 | 0.150 |
Why?
|
Aged, 80 and over | 13 | 2022 | 56770 | 0.150 |
Why?
|
Biological Availability | 1 | 2018 | 394 | 0.150 |
Why?
|
Protons | 1 | 2022 | 1117 | 0.140 |
Why?
|
Double-Blind Method | 3 | 2023 | 11938 | 0.140 |
Why?
|
Epidemiologic Studies | 2 | 2021 | 665 | 0.140 |
Why?
|
Apathy | 1 | 2017 | 93 | 0.140 |
Why?
|
Fever | 2 | 2021 | 1599 | 0.140 |
Why?
|
Calcitriol | 1 | 2018 | 288 | 0.140 |
Why?
|
Germ-Line Mutation | 2 | 2022 | 1764 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4433 | 0.140 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2017 | 106 | 0.140 |
Why?
|
Lipid Bilayers | 1 | 2018 | 376 | 0.140 |
Why?
|
Professional-Family Relations | 1 | 2000 | 479 | 0.140 |
Why?
|
Nursing Research | 1 | 2017 | 80 | 0.140 |
Why?
|
Biomimetics | 1 | 2017 | 170 | 0.140 |
Why?
|
Water | 1 | 2022 | 1391 | 0.140 |
Why?
|
Metagenomics | 4 | 2021 | 424 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2021 | 703 | 0.130 |
Why?
|
Prostaglandins | 1 | 2017 | 403 | 0.130 |
Why?
|
Prevalence | 3 | 2021 | 14976 | 0.130 |
Why?
|
Organoids | 1 | 2021 | 679 | 0.130 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 24714 | 0.130 |
Why?
|
Kinetics | 1 | 2023 | 6354 | 0.130 |
Why?
|
Mass Screening | 3 | 2020 | 5167 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1336 | 0.130 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15306 | 0.130 |
Why?
|
Sleep Deprivation | 1 | 2021 | 812 | 0.120 |
Why?
|
Bacteria | 3 | 2021 | 2111 | 0.120 |
Why?
|
Health Personnel | 4 | 2021 | 3153 | 0.120 |
Why?
|
Tumor Escape | 1 | 2017 | 349 | 0.120 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 1 | 2024 | 43 | 0.120 |
Why?
|
Sex Factors | 4 | 2021 | 10157 | 0.120 |
Why?
|
Glucose | 2 | 2023 | 4266 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2024 | 1675 | 0.120 |
Why?
|
Energy Intake | 1 | 2021 | 2110 | 0.110 |
Why?
|
Adolescent | 11 | 2021 | 85125 | 0.110 |
Why?
|
Dyslipidemias | 1 | 2020 | 839 | 0.110 |
Why?
|
Metabolomics | 1 | 2021 | 1507 | 0.110 |
Why?
|
Triglycerides | 1 | 2020 | 2358 | 0.110 |
Why?
|
Intestinal Mucosa | 2 | 2014 | 2970 | 0.100 |
Why?
|
Vitamin D Deficiency | 1 | 2022 | 1334 | 0.100 |
Why?
|
Educational Status | 1 | 2020 | 2459 | 0.100 |
Why?
|
ROC Curve | 1 | 2020 | 3457 | 0.100 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1853 | 0.100 |
Why?
|
Stilbenes | 1 | 2012 | 153 | 0.100 |
Why?
|
Peptides | 1 | 2024 | 4292 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 14815 | 0.100 |
Why?
|
Adenocarcinoma | 2 | 2022 | 6257 | 0.100 |
Why?
|
Tumor Microenvironment | 3 | 2020 | 3644 | 0.100 |
Why?
|
Age Factors | 4 | 2021 | 17982 | 0.100 |
Why?
|
Chromatography, Gel | 1 | 2012 | 648 | 0.100 |
Why?
|
Protein Disulfide-Isomerases | 1 | 2012 | 198 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2017 | 1427 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2557 | 0.090 |
Why?
|
Alleles | 1 | 2022 | 6795 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 1992 | 0.090 |
Why?
|
Models, Biological | 3 | 2021 | 9417 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 1079 | 0.090 |
Why?
|
Genes, ras | 1 | 2013 | 650 | 0.090 |
Why?
|
Cause of Death | 1 | 2020 | 3517 | 0.090 |
Why?
|
Phenotype | 4 | 2024 | 16066 | 0.090 |
Why?
|
Exercise | 2 | 2023 | 5577 | 0.090 |
Why?
|
Body Weight | 1 | 2020 | 4556 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2017 | 11939 | 0.080 |
Why?
|
Dementia | 1 | 2023 | 2495 | 0.080 |
Why?
|
Glomerular Filtration Rate | 3 | 2023 | 2079 | 0.080 |
Why?
|
Biological Transport | 2 | 2024 | 2078 | 0.080 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6155 | 0.080 |
Why?
|
Health Status | 2 | 2020 | 3966 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2407 | 0.080 |
Why?
|
Terminal Care | 1 | 2000 | 1664 | 0.080 |
Why?
|
Constipation | 2 | 2023 | 536 | 0.080 |
Why?
|
Genotype | 3 | 2024 | 12677 | 0.080 |
Why?
|
Ultraviolet Rays | 1 | 2013 | 1060 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3516 | 0.080 |
Why?
|
Phosphorylation | 2 | 2024 | 8267 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3627 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4212 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2259 | 0.080 |
Why?
|
Microfilament Proteins | 1 | 2023 | 1120 | 0.080 |
Why?
|
Nanotechnology | 1 | 2013 | 693 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8475 | 0.070 |
Why?
|
Genome, Human | 1 | 2020 | 4335 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4275 | 0.070 |
Why?
|
Sleep | 1 | 2022 | 4589 | 0.070 |
Why?
|
Risk | 2 | 2016 | 9455 | 0.070 |
Why?
|
Parents | 1 | 2000 | 3392 | 0.070 |
Why?
|
Decision Making | 1 | 2000 | 3807 | 0.070 |
Why?
|
Diet Surveys | 2 | 2021 | 1143 | 0.070 |
Why?
|
Genomics | 1 | 2022 | 5635 | 0.070 |
Why?
|
Protein Binding | 1 | 2018 | 9224 | 0.070 |
Why?
|
Diarrhea | 2 | 2023 | 1313 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2023 | 1632 | 0.070 |
Why?
|
Software | 1 | 2020 | 4370 | 0.070 |
Why?
|
Comorbidity | 1 | 2020 | 10203 | 0.070 |
Why?
|
Lipids | 1 | 2017 | 3209 | 0.070 |
Why?
|
Insulin | 1 | 2020 | 6393 | 0.070 |
Why?
|
Independent Living | 2 | 2020 | 547 | 0.060 |
Why?
|
Executive Function | 1 | 2024 | 1345 | 0.060 |
Why?
|
Menopause | 2 | 2024 | 1613 | 0.060 |
Why?
|
Molecular Epidemiology | 2 | 2017 | 452 | 0.060 |
Why?
|
Inflammation | 2 | 2023 | 10521 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1948 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9234 | 0.060 |
Why?
|
Body Mass Index | 3 | 2023 | 12489 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2017 | 2059 | 0.060 |
Why?
|
Epidemiologic Factors | 1 | 2024 | 36 | 0.060 |
Why?
|
Depression | 2 | 2021 | 7672 | 0.060 |
Why?
|
Animals | 6 | 2024 | 165479 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9150 | 0.060 |
Why?
|
Histones | 1 | 2014 | 2551 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3527 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2024 | 2693 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2327 | 0.050 |
Why?
|
Archaea | 1 | 2023 | 59 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5737 | 0.050 |
Why?
|
Cytokines | 1 | 2017 | 7175 | 0.050 |
Why?
|
Trophoblasts | 1 | 2023 | 207 | 0.050 |
Why?
|
Electron Transport Complex IV | 1 | 2022 | 188 | 0.050 |
Why?
|
Neoplasms | 2 | 2020 | 21375 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5702 | 0.050 |
Why?
|
Body Size | 1 | 2024 | 449 | 0.050 |
Why?
|
Satiation | 1 | 2021 | 82 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2023 | 619 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 5973 | 0.050 |
Why?
|
Prevotella | 1 | 2021 | 77 | 0.050 |
Why?
|
Meat | 1 | 2024 | 573 | 0.050 |
Why?
|
Food Microbiology | 1 | 2021 | 77 | 0.050 |
Why?
|
Blastocystis | 1 | 2021 | 19 | 0.050 |
Why?
|
Southeastern United States | 1 | 2000 | 87 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2023 | 3292 | 0.050 |
Why?
|
Hong Kong | 1 | 2000 | 152 | 0.050 |
Why?
|
Taste Disorders | 1 | 2020 | 35 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2014 | 8301 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11203 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2020 | 50 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2023 | 830 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 169 | 0.040 |
Why?
|
Hunger | 1 | 2021 | 192 | 0.040 |
Why?
|
England | 1 | 2020 | 517 | 0.040 |
Why?
|
Sulfur | 1 | 2020 | 162 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8140 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2023 | 587 | 0.040 |
Why?
|
Glycemic Index | 1 | 2021 | 387 | 0.040 |
Why?
|
Neoplasm Seeding | 1 | 2019 | 85 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2020 | 276 | 0.040 |
Why?
|
Life Support Care | 1 | 2000 | 216 | 0.040 |
Why?
|
Sigmoidoscopy | 1 | 2019 | 151 | 0.040 |
Why?
|
Israel | 1 | 2021 | 785 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7126 | 0.040 |
Why?
|
Computer Systems | 1 | 2020 | 470 | 0.040 |
Why?
|
Individuality | 1 | 2020 | 298 | 0.040 |
Why?
|
C-Peptide | 1 | 2020 | 413 | 0.040 |
Why?
|
Hormone Replacement Therapy | 1 | 2024 | 727 | 0.040 |
Why?
|
Resuscitation Orders | 1 | 2000 | 262 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2021 | 2814 | 0.040 |
Why?
|
Mental Health | 2 | 2022 | 2991 | 0.040 |
Why?
|
Olfaction Disorders | 1 | 2020 | 214 | 0.040 |
Why?
|
Public Health | 2 | 2021 | 2572 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13478 | 0.040 |
Why?
|
Estrogen Replacement Therapy | 1 | 2024 | 1202 | 0.040 |
Why?
|
Thermus thermophilus | 1 | 2017 | 19 | 0.040 |
Why?
|
Australia | 1 | 2000 | 1160 | 0.040 |
Why?
|
Glucose Tolerance Test | 1 | 2020 | 1130 | 0.040 |
Why?
|
Cross-Cultural Comparison | 1 | 2000 | 628 | 0.040 |
Why?
|
Levodopa | 1 | 2017 | 219 | 0.040 |
Why?
|
Protein Unfolding | 1 | 2017 | 51 | 0.040 |
Why?
|
Odds Ratio | 2 | 2021 | 9542 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 1973 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1154 | 0.030 |
Why?
|
Safety | 1 | 2021 | 1150 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 961 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 11609 | 0.030 |
Why?
|
Vaccines, DNA | 1 | 1997 | 288 | 0.030 |
Why?
|
Eating | 1 | 2022 | 1522 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 831 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2021 | 542 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2021 | 2906 | 0.030 |
Why?
|
Estrogens | 1 | 2022 | 1517 | 0.030 |
Why?
|
Dietary Carbohydrates | 1 | 2020 | 882 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2738 | 0.030 |
Why?
|
Crack Cocaine | 1 | 1995 | 33 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2023 | 62430 | 0.030 |
Why?
|
Binding Sites | 1 | 2024 | 6009 | 0.030 |
Why?
|
Dopamine Agonists | 1 | 2017 | 348 | 0.030 |
Why?
|
Dietary Proteins | 1 | 2020 | 924 | 0.030 |
Why?
|
Postmenopause | 1 | 2024 | 2445 | 0.030 |
Why?
|
Colectomy | 1 | 2020 | 661 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 728 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1534 | 0.030 |
Why?
|
Heart Failure | 1 | 2018 | 10335 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1069 | 0.030 |
Why?
|
Minority Groups | 1 | 2022 | 1184 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1730 | 0.030 |
Why?
|
DNA Damage | 1 | 2024 | 2368 | 0.030 |
Why?
|
Chest Pain | 1 | 2021 | 1090 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 766 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14501 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1691 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1299 | 0.030 |
Why?
|
Random Allocation | 1 | 2018 | 2370 | 0.030 |
Why?
|
Vitamins | 1 | 2022 | 1598 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2022 | 4102 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 1958 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2020 | 1723 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1503 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2020 | 1230 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 280 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2020 | 2269 | 0.030 |
Why?
|
Dietary Fats | 1 | 2020 | 1973 | 0.030 |
Why?
|
Antigens, Bacterial | 1 | 1997 | 1152 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 863 | 0.020 |
Why?
|
Polysomnography | 1 | 2017 | 1774 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 493 | 0.020 |
Why?
|
Phylogeny | 1 | 2018 | 2754 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 877 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2000 | 5017 | 0.020 |
Why?
|
Viral Proteins | 1 | 2017 | 1805 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2020 | 2885 | 0.020 |
Why?
|
Cocaine | 1 | 1995 | 975 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2022 | 3901 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3720 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1673 | 0.020 |
Why?
|
Bacterial Infections | 1 | 1997 | 1384 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1836 | 0.020 |
Why?
|
Vitamin D | 1 | 2022 | 3205 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7616 | 0.020 |
Why?
|
Rats | 1 | 2024 | 23644 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 76887 | 0.020 |
Why?
|
Nurses | 1 | 2017 | 2434 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8500 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9829 | 0.020 |
Why?
|
Mortality | 1 | 2018 | 2812 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9009 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1339 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2023 | 11313 | 0.020 |
Why?
|
Emotions | 1 | 2017 | 2630 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6666 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9141 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5045 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2012 | 6142 | 0.020 |
Why?
|
Genetic Variation | 1 | 2020 | 6412 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2017 | 2789 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2017 | 3781 | 0.010 |
Why?
|
Kidney | 1 | 2018 | 6915 | 0.010 |
Why?
|
Child | 2 | 2021 | 77344 | 0.010 |
Why?
|
Chromatin | 1 | 2014 | 2883 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12733 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 7637 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5807 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7159 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1880 | 0.010 |
Why?
|
Heart Diseases | 1 | 1995 | 2706 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 28985 | 0.010 |
Why?
|
Thrombosis | 1 | 1995 | 2928 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2014 | 7582 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 1995 | 4196 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10250 | 0.010 |
Why?
|
Chlamydia trachomatis | 1 | 1997 | 233 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 14761 | 0.010 |
Why?
|
Echocardiography | 2 | 1995 | 4772 | 0.010 |
Why?
|
Mice | 1 | 2021 | 79548 | 0.010 |
Why?
|
Chlamydia Infections | 1 | 1997 | 357 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1995 | 11247 | 0.010 |
Why?
|
Heart Ventricles | 2 | 1995 | 3710 | 0.000 |
Why?
|
Mycobacterium tuberculosis | 1 | 1997 | 1850 | 0.000 |
Why?
|
Tuberculosis | 1 | 1997 | 1906 | 0.000 |
Why?
|
Electrocardiography | 1 | 1995 | 6222 | 0.000 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1979 | 460 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1979 | 1021 | 0.000 |
Why?
|
Radiography | 1 | 1979 | 6932 | 0.000 |
Why?
|
Coronary Disease | 1 | 1979 | 5859 | 0.000 |
Why?
|